HAX1 and cancer: Thus, our study reveals a previously unidentified mechanism by which a histone methylation modifier is primarily involved in mitochondria-mediated apoptosis, by epigenetic regulation of HAX1. These results indicate that KDM4B may be an ideal target for cancer therapy.